Recalls of generic Zantac believed to be contaminated by a carcinogen continue to flood in. Two other firms have declared recalls of ranitidine heartburn meds in 150 mg and 300 mg doses. The news arrived even as the degree of the drug returns increased with Mylan’s impromptu recall of three lots of nizatidine capsules last week because the API in them also held dangerous levels of NDMA.
Shortly after the Federal officials announced the voluntary recalls of some pharmacies over NDMA, a drug filled with a potential human carcinogen, many other pharmacies have recalled the common variety of heartburn drug Zantac, called ranitidine, from shelves.
Additional generic editions of Zantac are being taken down from pharmacy shelves after officials detected low levels of a possible carcinogens in the heartburn medication.
The Stryker Tritanium Acetabular Shell, which restores the human hip socket, is built from a titanium alloy covered with a unique kind of porous foam. The foam enables bone cells to bind with it and grow, thereby increasing joint stability. However, a 2018 report in the journal Arthroplasty Today by doctors at NYU Langone Orthopedic Hospitals described five hip implant failures related to Stryker’s Tritanium cups between 2011 and 2016.
Green, Schafle & Gibbs has launched an investigation into the alleged Ponzi Scheme operated by Philadelphia-area stockbroker Paul W. Smith. Based in Wayne, PA, Smith operated a long-running Ponzi Scheme using purported investments in The Haverford Group, which costs a group of mostly retired and elderly investors approximately $2.35 million, according to the SEC.
There’s a universe of advice and information out there for investors looking to educate and protect themselves. Tune in to MSNBC or visit TheStreet.com and you’ll find a million answers to million different questions related to investing intelligently. But for all this “noise” about investing, there is some basic, critical information you probably will not hear about that could make all the difference to your financial well-being.
Getting hip implant surgery these days is easy enough. Unfortunately the problems tend to start after the procedure, when many patients notice symptoms and side-effects related to defective hip implant technology. In some cases, the technology is so dangerous - and causes so much pain - that hip implant revision surgery becomes necessary. In such cases, you may need to explore your legal rights.
In a notable FINRA arbitration award released late last month from a Philadelphia, Pennsylvania Arbitrator. Philadelphia-based FINRA attorney arbitration law firm, Green, Schafle & Gibbs, has secured a more than $63,000 arbitration award from brokerage firm Morgan Stanley Smith Barney to an investor who had sought $80,000 in financial damages.
A bellwether trial on October 23, 2017 will structure arguments for future matters pertaining to faulty IVC filter devices. This case is relevant for victims of faulty IVC filters because it will determine whether the manufacturer was negligent in selling and producing a product that has allegedly caused a number of injuries and fatalities.
In 2010, the FDA issued a safety warning over inferior vena cava (IVC) filters, a type of vascular filter implanted into the heart by radiologists or surgeons in order to presumably prevent life-threatening pulmonary emboli (PEs). In the years following the warning, the rate of implantation slowed, although it is still more than 10x higher than in Europe.
2332 South Broad Street
Philadelphia PA 19145
p: 215 462 3330 / f: 215-567-1941
